BIOMAT Database Logo BIOMAT Database Logo

Screening, brief intervention, and referral to treatment (SBIRT) for cannabis: A scoping review. 2023

J A Gette, and T Regan, and J A Schumacher
Center for Alcohol and Substance Use Studies, Rutgers, the State University of New Jersey, Piscataway, NJ, United States of America. Electronic address: Jordan.gette@rutgers.edu.

Screening, brief intervention, and referral to treatment (SBIRT) has been used to change substance use behavior. Despite cannabis being the most prevalent federally illicit substance, we have limited understanding of use of SBIRT for managing cannabis use. This review aimed to summarize the literature on SBIRT for cannabis use across age groups and contexts over the last two decades. This scoping review followed the a priori guide outlined by the PRISMA (Preferred Reporting Items for Scoping Reviews and Meta-Analyses) statement. We gathered articles from PsycINFO, PubMed, Sage Journals Online, ScienceDirect, and SpringerLink. The final analysis includes forty-four articles. Results indicate inconsistent implementation of universal screens and suggest screens assessing cannabis-specific consequences and utilizing normative data may increase patient engagement. Broadly, SBIRT for cannabis demonstrates high acceptability. However, the impact of SBIRT on behavior change across various modifications to intervention content and modality has been inconsistent. In adults, patients with primary cannabis use are not engaging in recommended treatment at similar rates to other substances. Results also suggest a lack of research addressing referral to treatment in adolescents and emerging adults. Based on this review, we offer several to improve each component of SBRIT that may increase implementation of screens, effectiveness of brief interventions, and engagement in follow-up treatment.

UI MeSH Term Description Entries
D012017 Referral and Consultation The practice of sending a patient to another program or practitioner for services or advice which the referring source is not prepared to provide. Consultation,Gatekeepers, Health Service,Hospital Referral,Second Opinion,Consultation and Referral,Health Service Gatekeepers,Hospital Referrals,Referral,Referral, Hospital,Referrals, Hospital,Consultations,Gatekeeper, Health Service,Health Service Gatekeeper,Opinion, Second,Opinions, Second,Referrals,Second Opinions
D002188 Cannabis The plant genus in the Cannabaceae plant family, Urticales order, Hamamelidae subclass. The flowering tops are called many slang terms including pot, marijuana, hashish, bhang, and ganja. The stem is an important source of hemp fiber. Bhang,Ganja,Hashish,Hemp,Cannabis indica,Cannabis sativa,Hemp Plant,Marihuana,Marijuana,Bhangs,Cannabi,Ganjas,Hashishs,Hemp Plants,Hemps,Plant, Hemp,Plants, Hemp
D003419 Crisis Intervention Brief therapeutic approach which is ameliorative rather than curative of acute psychiatric emergencies. Used in contexts such as emergency rooms of psychiatric or general hospitals, or in the home or place of crisis occurrence, this treatment approach focuses on interpersonal and intrapsychic factors and environmental modification. (APA Thesaurus of Psychological Index Terms, 7th ed) Brief Advice,Brief Interventions,Brief Treatment,Critical Incident Stress Debriefing,Screening and Brief Intervention,Advice, Brief,Brief Intervention,Brief Treatments,Crisis Interventions,Intervention, Brief,Intervention, Crisis,Treatment, Brief
D006213 Hallucinogens Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise. Hallucinogen,Hallucinogenic Agent,Hallucinogenic Drug,Hallucinogenic Substance,Psychedelic,Psychedelic Agent,Psychedelic Agents,Psychotomimetic Agent,Psychotomimetic Agents,Hallucinogenic Agents,Hallucinogenic Drugs,Hallucinogenic Substances,Psychedelics,Agent, Hallucinogenic,Agent, Psychedelic,Agent, Psychotomimetic,Agents, Hallucinogenic,Agents, Psychedelic,Agents, Psychotomimetic,Drug, Hallucinogenic,Drugs, Hallucinogenic,Substance, Hallucinogenic,Substances, Hallucinogenic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D063386 Cannabinoid Receptor Agonists Compounds that interact with and stimulate the activity of CANNABINOID RECEPTORS. Cannabinoid Agonist,Cannabinoid Receptor Agonist,Cannabinoid Agonists,Cannabinoid Receptor Activators,Activators, Cannabinoid Receptor,Agonist, Cannabinoid,Agonist, Cannabinoid Receptor,Agonists, Cannabinoid,Agonists, Cannabinoid Receptor,Receptor Activators, Cannabinoid,Receptor Agonist, Cannabinoid,Receptor Agonists, Cannabinoid

Related Publications

J A Gette, and T Regan, and J A Schumacher
Integrating screening, brief intervention, and referral to treatment (SBIRT) into clinical practice settings: a brief review.
January 2012, Journal of psychoactive drugs,
J A Gette, and T Regan, and J A Schumacher
Strategies to promote the implementation of Screening, Brief Intervention, and Referral to Treatment (SBIRT) in healthcare settings: a scoping review.
May 2021, Substance abuse treatment, prevention, and policy,
J A Gette, and T Regan, and J A Schumacher
Alcohol Screening, Brief Intervention, and Referral to Treatment (SBIRT) for Girls and Women.
January 2020, Alcohol research : current reviews,
J A Gette, and T Regan, and J A Schumacher
Screening brief intervention and referral to treatment (SBIRT) saves lives and improves health.
July 2010, The Journal of the Oklahoma State Medical Association,
J A Gette, and T Regan, and J A Schumacher
Screening, brief intervention, and referral to treatment (SBIRT) curricular innovations: addressing a training gap.
January 2012, Substance abuse,
J A Gette, and T Regan, and J A Schumacher
Screening, brief intervention, and referral to treatment (SBIRT) for offenders: protocol for a pragmatic randomized trial.
October 2013, Addiction science & clinical practice,
J A Gette, and T Regan, and J A Schumacher
[Screening, Brief Intervention, Referral to Treatment(SBIRT) model for alcohol use disorder in Japan].
September 2015, Nihon rinsho. Japanese journal of clinical medicine,
J A Gette, and T Regan, and J A Schumacher
Electronic-Screening, Brief Intervention and Referral to Treatment (e-SBIRT) for Addictive Disorders: Systematic Review and Meta-Analysis.
May 2024, Substance use & addiction journal,
J A Gette, and T Regan, and J A Schumacher
Integrating Screening, Brief Intervention and Referral to Treatment (SBIRT) for Substance Use into Prenatal Care.
April 2020, Maternal and child health journal,
J A Gette, and T Regan, and J A Schumacher
Screening, Brief Intervention, Referral to Treatment (SBIRT), and Motivational Interviewing for PGY-1 Medical Residents.
December 2014, Journal of graduate medical education,
Copied contents to your clipboard!